Dental amalgams
This article was originally published in The Gray Sheet
Executive Summary
Stakeholders are granted an additional month to send FDA peer-reviewed articles dealing with dental amalgam health risks. Submissions are now due by July 1 (1"The Gray Sheet" May 12, 2003, In Brief)...
You may also be interested in...
Dental amalgam call-for-papers
FDA seeks reference information for peer-reviewed journal articles that discuss the health impact of dental amalgam and were published from Jan. 1, 1996 to June 1, 2003. Submissions to FDA are due by June 2. The 1May 9 request is part of FDA's preparation for the latest in a series of literature reviews on the topic that will start later this year. Sponsored by FDA, CDC and the National Institute of Dental & Craniofacial Research, the review will be conducted by an independent group. Prior reviews concluded that, for the most part, dental amalgam poses no serious health threat. Last month, however, Rep. Diane Watson (R-Calif.) introduced 2HR 1680, a bill seeking to ban use of mercury fillings introduced into interstate commerce after 2008...
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.